Approved for patients 5 years or older with sickle cell disease.
Patients treated with L-glutamine versus placebo had fewer hospitalizations, sickle cell crises, fewer days spent in the hospital, than placebo.
Associated with fewer chest crises.
Most common adverse events: Constipation, nausea, abdominal pain, headache, cough, extremity back and chest pain.